Joint Letter to Congressional Leaders Opposing Allergan's Actions to Prevent Generic Competition

Michael Brzica

allergan; restasis; patent; patent and trademark office; pto; st. regis mohawk tripl america invents act; ip inversion; drug price; rx; prescription drugs

Tue, 10/10/2017 - 1:46 PM EDT

Tue, 10/10/2017 - 3:22 PM EDT

3

joint_letter_to_congressional_leaders_opposing_allergans_actions_to_prevent_generic_competition_2017.pdf

{"Author":"Michael Brzica","CreationDate":"2017-10-10T13:46:42-04:00","Creator":"Microsoft\u00ae Word 2016","Keywords":"allergan; restasis; patent; patent and trademark office; pto; st. regis mohawk tripl america invents act; ip inversion; drug price; rx; prescription drugs\r\n","ModDate":"2017-10-10T15:22:44-04:00","Producer":"Microsoft\u00ae Word 2016","Title":"Joint Letter to Congressional Leaders Opposing Allergan's Actions to Prevent Generic Competition","Pages":3,"pdf:producer":"Microsoft\u00ae Word 2016","pdf:keywords":"allergan; restasis; patent; patent and trademark office; pto; st. regis mohawk tripl america invents act; ip inversion; drug price; rx; prescription drugs\r\n","dc:format":"application\/pdf","dc:creator":"Michael Brzica","dc:title":"Joint Letter to Congressional Leaders Opposing Allergan's Actions to Prevent Generic Competition","dc:subject":["allergan","restasis","patent","patent and trademark office","pto","st. regis mohawk tripl america invents act","ip inversion","drug price","rx","prescription drugs"],"xmp:creatortool":"Microsoft\u00ae Word 2016","xmp:createdate":"2017-10-10T13:46:42-04:00","xmp:modifydate":"2017-10-10T15:22:44-04:00","xmp:metadatadate":"2017-10-10T15:22:44-04:00","xmpmm:documentid":"uuid:B2F90CA8-0088-4B41-B7AC-FE7AC5CBCFEA","xmpmm:instanceid":"uuid:32da8e04-d208-44d4-84b0-39d3f66e701e"}

2017